Emergency : 011-35353535 
Dr. Pallavi Redhu
Designation : Consultant - Medical Oncology
Speciality : Oncology (Cancer)
Areas of Expertise : Oncology
Qualification : MD, DrNB (Medical Oncology)
Dr. Pallavi Redhu is a distinguished Consultant Medical Oncologist with a comprehensive educational background and extensive expertise in oncology. She completed her DrNB in Medical Oncology from Rajiv Gandhi Cancer Institute, Delhi, and her MD in Radiation Oncology from Gandhi Medical College, Bhopal, following her MBBS from Adichunchanagiri Institute Of Medical Sciences, Karnataka. Dr. Redhu excels in managing diverse relationships with colleagues, patients, and their families, and is adept in operating medical equipment related to cancer. Her areas of interest include Pediatric Oncology and Gynecological Oncology, and she is skilled in leading multidisciplinary teams and solving complex diagnostic problems.
- 2023- July 2024 - Consultant Medical Oncologist at Jaypee Hospital,Noida
- 2022- 2023- Consultant Medical Oncologist at Rajiv Gandhi Cancer Institute and Research center at Delhi
- 2019 -2022- Senior resident , Department of medical oncology at Rajiv Gandhi Cancer Institute and research center at Delhi
- 2018-2019- Senior Resident clinical oncology at Delhi state cancer institute
- 2015- 2018- Junior resident , Department of radiation oncology at Gandhi Medical College , Bhopal.
- Breast cancer
- Gynecological cancer (ovarian, uterine,cervical)
- Gastrointestinal cancer
- Lung cancer
- Head and neck cancer
- Hematological malignancy- lymphoma, myeloma, chronic leukaemia
- Cancer screening and hereditary tumours
- Chemotherapy
- Hormonal therapy
- Cancer vaccination
- Immunotherapy and targeted therapy
- Precision oncology
- Palliative and preventive oncology
- Jain A, Koyyala VP, Narayan S, Soni S, Redhu P, Jaju A. Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy. Indian Journal of Medical and Paediatric Oncology. 2022 Apr;43(02):185-8.
- Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World Journal of Clinical Oncology. 2022 May 5;13(5):339.
- Agrawal C, Goyal P, Jain P, Domadia K, Redhu P, Doval DC. Colonic polyp-rare site of metastasis from primary lung carcinoma: Clinical presentations and outcome. Lung India: Official Organ of Indian Chest Society. 2021 Nov;38(6):581.
- Goyal P, Doval DC, Agarwal C, Jain P, Chaudhari K, Domadia K, Redhu P, Koyyala VP, Goel V, Batra U, Talwar V. Current Treatment Approaches for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in Adjuvant and Neoadjuvant Settings. Indian Journal of Medical and Paediatric Oncology. 2021 Feb;42(01):035-45.
- Batra U, Sharma M, Redhu P. Chloroquine and hydroxychloroquine: Clutching at straws in the time of COVID-19?. Cancer Research, Statistics, and Treatment. 2020 Apr 1;3(5):3.
- Singh OP, Yogi V, Redhu P, Ghori HU, Pareek A, Lal N. Role of serum prostate-specific antigen as predictor for bone metastases in newly diagnosed prostate cancer. Journal of cancer research and therapeutics. 2019 Mar 1;15(8):39.
- Pareek A, Singh OP, Yogi V, Ghori HU, Tiwari V, Redhu P. Bone metastases incidence and its correlation with hormonal and human epidermal growth factor receptor 2 neu receptors in breast cancer. Journal of Cancer Research and Therapeutics. 2019 Jul 1;15(5):971.
- Yogi V, Singh OP, Redhu P, Francis B. Extranodal Non-Hodgkin Lymphomas: The Impact of Different Variables on the Disease. Middle East Journal of Cancer. 2019 Oct 1;10(4):324-32.
- SINGH O, Yogi V, Redhu P. Spectrum Of Extranodal Non Hodgkin'S Lymphoma: Evaluation Of Prognostic Factors And Treatment Response. Journal of Cancer Research & Therapeutics. 2017 Dec 2;13.
- Sharma M, Nathany S, Narayan S, Redhu P, Jain P, Batra U. Real-world data of osimertinib in the management of leptomeningeal metastases in EGFR mutant NSCLC: Light at the end of the tunnel?.
- Pallavi Redhu, O.P. Singh, H.U. Ghori, V Yogi. Impact of pelvic irradiation on bone mineral density in cervical cancer patients: Poster Presentation RGCON February 2018
- Pallavi Redhu, O. P. singh, H. U. Ghori, V Yogi. Orbital metastases in Ewing’s Sarcoma: A rare cause of Outstanding research work : NBE 2023
ORAL & POSTER PRESENTATIONS:
- Delhi Medical council
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Indian Society of Medical and Pediatric Oncology (ISMPO)
© 2023 Kailash Deepak Hospital. All Rights Reserved.
